Cargando…

Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend

Purpose: The objective for this clinical pilot study was to evaluate changes to chronic pain, vascular health, and inflammatory markers when consuming a dietary supplement blend (DSB, CytoQuel(®)), containing curcumin, resveratrol, tocotrienols, N-Acetylcysteine, and epigallocatechin gallate. Materi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Debby E, Jensen, Gitte S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526776/
https://www.ncbi.nlm.nih.gov/pubmed/31190960
http://dx.doi.org/10.2147/JPR.S189064
_version_ 1783419954020745216
author Hamilton, Debby E
Jensen, Gitte S
author_facet Hamilton, Debby E
Jensen, Gitte S
author_sort Hamilton, Debby E
collection PubMed
description Purpose: The objective for this clinical pilot study was to evaluate changes to chronic pain, vascular health, and inflammatory markers when consuming a dietary supplement blend (DSB, CytoQuel(®)), containing curcumin, resveratrol, tocotrienols, N-Acetylcysteine, and epigallocatechin gallate. Materials and methods: An open-label study design was used where 21 study participants were evaluated at baseline and at 2 and 8 weeks after consuming DSB. Participants were randomized to consume 3 capsules once daily versus 2 capsules twice daily. Pain and activities of daily living questionnaires were used to gather subjective data on pain levels and interference with daily living. Blood pressure was measured in both arms and ankles, and the ankle-brachial index (ABI) calculated. Blood samples were used to evaluate markers associated with inflammation and cardiovascular health. Results: Highly significant reduction of chronic pain was seen after 8 weeks (p<0.01), both at rest and when physically active. Faster improvement was seen when consuming 3 capsules once daily, compared to 2 capsules twice daily. The pain reduction resulted in improved sleep quality (p<0.1), and improved social functioning (p<0.01), and less need for support from others (p<0.05), Normalization of mildly elevated ABI at study start was seen after 2 weeks. Plasma fibrinogen and von Willebrand Factor and serum matrix metalloproteinase-9 (MMP-9) showed reduction after 2 weeks (not significant), whereas a reduction in serum interleukin-1 receptor antagonist-a (IL-1ra) was statistically significant after 2 weeks (p<0.05). Correlation between pain reduction and changes to MMP-9 after 8 weeks was highly significant (P<0.01), whereas correlation between pain reduction and changes to IL-1ra reached significance at 2 weeks for the group consuming 3 caps once daily (p<0.04). Conclusion: Consuming DSB helped manage pain, increased comfort during daily activities, and improved vascular function. This was associated with selective effects on specific blood biomarkers associated with inflammation and vascular health.
format Online
Article
Text
id pubmed-6526776
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65267762019-06-12 Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend Hamilton, Debby E Jensen, Gitte S J Pain Res Original Research Purpose: The objective for this clinical pilot study was to evaluate changes to chronic pain, vascular health, and inflammatory markers when consuming a dietary supplement blend (DSB, CytoQuel(®)), containing curcumin, resveratrol, tocotrienols, N-Acetylcysteine, and epigallocatechin gallate. Materials and methods: An open-label study design was used where 21 study participants were evaluated at baseline and at 2 and 8 weeks after consuming DSB. Participants were randomized to consume 3 capsules once daily versus 2 capsules twice daily. Pain and activities of daily living questionnaires were used to gather subjective data on pain levels and interference with daily living. Blood pressure was measured in both arms and ankles, and the ankle-brachial index (ABI) calculated. Blood samples were used to evaluate markers associated with inflammation and cardiovascular health. Results: Highly significant reduction of chronic pain was seen after 8 weeks (p<0.01), both at rest and when physically active. Faster improvement was seen when consuming 3 capsules once daily, compared to 2 capsules twice daily. The pain reduction resulted in improved sleep quality (p<0.1), and improved social functioning (p<0.01), and less need for support from others (p<0.05), Normalization of mildly elevated ABI at study start was seen after 2 weeks. Plasma fibrinogen and von Willebrand Factor and serum matrix metalloproteinase-9 (MMP-9) showed reduction after 2 weeks (not significant), whereas a reduction in serum interleukin-1 receptor antagonist-a (IL-1ra) was statistically significant after 2 weeks (p<0.05). Correlation between pain reduction and changes to MMP-9 after 8 weeks was highly significant (P<0.01), whereas correlation between pain reduction and changes to IL-1ra reached significance at 2 weeks for the group consuming 3 caps once daily (p<0.04). Conclusion: Consuming DSB helped manage pain, increased comfort during daily activities, and improved vascular function. This was associated with selective effects on specific blood biomarkers associated with inflammation and vascular health. Dove 2019-05-15 /pmc/articles/PMC6526776/ /pubmed/31190960 http://dx.doi.org/10.2147/JPR.S189064 Text en © 2019 Hamilton and Jensen. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hamilton, Debby E
Jensen, Gitte S
Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend
title Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend
title_full Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend
title_fullStr Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend
title_full_unstemmed Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend
title_short Pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend
title_sort pain reduction and improved vascular health associated with daily consumption of an anti-inflammatory dietary supplement blend
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526776/
https://www.ncbi.nlm.nih.gov/pubmed/31190960
http://dx.doi.org/10.2147/JPR.S189064
work_keys_str_mv AT hamiltondebbye painreductionandimprovedvascularhealthassociatedwithdailyconsumptionofanantiinflammatorydietarysupplementblend
AT jensengittes painreductionandimprovedvascularhealthassociatedwithdailyconsumptionofanantiinflammatorydietarysupplementblend